Dr. Jolly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4131
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of North Carolina HospitalsFellowship, Geriatric Medicine (Internal Medicine), 2010 - 2011
- University of Alabama Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2009 - 2010
- New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2006 - 2009
- University of the West Indies Faculty of MedicineClass of 2002
Certifications & Licensure
- NC State Medical License 2010 - 2025
- WA State Medical License 2023 - 2024
- AL State Medical License 2009 - 2010
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer Start of enrollment: 2012 Dec 11
- The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer Start of enrollment: 2014 Mar 01
- Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.Ryan T Morse, Nathan W Bean, Jacob Hall, Allison Deal, Kirsten A Nyrop
Clinical Breast Cancer. 2025-01-01 - 5 citationsA phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, accep...Zev M Nakamura, Allison M Deal, Eliza M Park, Kate E Stanton, Yesy E Lopez
Cancer Medicine. 2023-04-01 - 3 citationsA biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.Natalia Mitin, Kirsten A Nyrop, Susan L Strum, Anne Knecht, Lisa A Carey
NPJ Breast Cancer. 2022-09-08
Journal Articles
- Intensive Smoking Cessation Counseling for Patients with CancerTrevor Jolly, MD, JAMA
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: